DIA Announces 2011-2012 Board of Directors at DIA 2011

CHICAGO--(BUSINESS WIRE)-- DIA today announced its 2011-2012 Board of Directors. The announcement came during DIA 2011 being held June 19-23 in Chicago, IL. The Board of Directors set the overall strategy for DIA activities.

Executive Committee:

  • Dr. Yves Juillet, DIA President, LEEM, France
  • Ling Su, DIA President-elect, Novartis Pharmaceuticals, China
  • Dr. Richard Day, DIA Immediate-past President
  • Minnie Baylor-Henry, DIA Treasurer, Johnson & Johnson Medical Devices & Diagnostics, USA

Directors:

  • Michele Livesey, Livesey Consulting, USA
  • Dr. Sandra Milligan, Amgen, USA
  • Dr. Sandra L. Kweder, FDA, USA
  • Dr. Steve Caffé, Medimmune, USA
  • Truus Janse-de Hoog, Medicines Evaluation Board, The Netherlands
  • Dr. Thomas Kühler, GE Healthcare Bio-Sciences, Sweden
  • John A. Roberts, InfoLogix, USA
  • Dr. Per Spindler, University of Copenhagen, Denmark
  • Dr. Jean A Yager, BioPharm People, USA

Regional Advisory Council Chairs:

  • Larisa Nagra Singh, DIA Advisory Council of India, Voisin Consulting Life Sciences, India
  • Dr. Ning Xu, DIA Advisory Council of China, Covance Pharmaceutical R&D (Beijing)
  • Dr. Jennifer L. Riggins, DIA Advisory Council of North America, Eli Lilly and Company, US
  • Beat Widler, DIA Advisory Council of Europe, Clinical Quality and Risk Management Expert
  • Dr. Tatsuo Kurokawa, DIA Advisory Council of Japan, Keio University Faculty of Pharmacy

“Being an effective global community is a core component of DIA’s mission,” says Paul Pomerantz, DIA Worldwide Executive Director. “That’s why I want to personally recognize and thank each member of our Board of Directors comprised as it is of dedicated volunteers from every continent.”

ABOUT DIA

DIA is a neutral, global, professional, member-driven association of nearly 18,000 professionals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices, and related health care products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies, and services to improve health and well being worldwide. Headquarters are in Horsham, PA, USA, with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China.



CONTACT:

DIA
Joe Krasowski, 215-293-5812
Marketing Communications Manager

KEYWORDS:   United States  Europe  North America  Illinois

INDUSTRY KEYWORDS:   Health  Biotechnology  Medical Devices  Pharmaceutical  Communications  Public Relations/Investor Relations  General Health

MEDIA:

Logo
 Logo

Suggested Articles

Six pharmaceutical execs are set to head to Washington next week for pricing hearings at the House Committee on Oversight and Reform. 

After sifting through the data, one analyst figures the latest Opdivo-Keytruda showdown in kidney cancer might come down to commercial execution.

Biogen is giving former chief finance officer Jeff Capello a multimillion-dollar cash payment plus other severance benefits.